Organization · Tulsa and Oklahoma ecosystem

Cadenza Bio

Drug development. Listed in the linked investors’ public portfolios; a portfolio listing does not establish current operating or fundraising status.

For example: Explore Cadenza Bio through its official site and connected entries to check whether it fits your needs.

Funding

  • Reported $2,440,000 sold of a $2,440,000 offering in an SEC Form D filed in August 2025. Source: sec.gov

Figures are as published by the linked source.

Official site: cadenza.bio

Connects to 5

Sources

Page last changed · Suggest a correction